Figures and tables index

From the following article

Albinterferon alpha-2b: a genetic fusion protein for the treatment of chronic hepatitis C

G Mani Subramanian, Michele Fiscella, Araba Lamousé-Smith, Stefan Zeuzem & John G McHutchison

Nature Biotechnology 25, 1411 - 1419 (2007) Published online: 7 December 2007

doi:10.1038/nbt1364

BACK TO ARTICLE
Figure 1 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 1

Key attributes of the albumin-fusion technology platform.

Full size figure and legend (87 KB)
Figure 2 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 2

Biochemical characterization of alb-IFN.

Full size figure and legend (107 KB)
Figure 3 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 3

In vitro antiviral activity.

Full size figure and legend (69 KB)
Figure 4 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 4

Pharmacokinetics and viral kinetics of alb-IFN.

Full size figure and legend (68 KB)
Figure 5 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 5

Clinical pharmacology in IFN non-responders and treatment-naive individuals with CHC.

Full size figure and legend (86 KB)
Figure 6 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 6

Clinical development program overview.

Full size figure and legend (104 KB)
Table 1 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Table 1

Currently available approaches to enhance polypeptide pharmacokinetics

Full size table and legend
Table 2 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Table 2

Clinical studies with albumin-fusion products

Full size table and legend
BACK TO ARTICLE